Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3587 USD | +10.85% | +6.76% | -41.20% |
Mar. 21 | Dermata Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 05 | Wall Street Set to Open Lower as Monthly Jobs Data Much Stronger Than Expected | MT |
Chart calendar Dermata Therapeutics, Inc.
Upcoming events on Dermata Therapeutics, Inc.
Past events on Dermata Therapeutics, Inc.
2024-05-07 12:00 pm | Annual General Meeting |
2024-04-03 03:55 pm | Emerging Growth Conference |
2024-03-21 04:05 pm | Q4 2023 Earnings Release |
2024-02-07 12:35 pm | Emerging Growth Conference |
2024-01-12 12:00 pm | Extraordinary Shareholders Meeting |
2023-11-09 04:05 pm | Q3 2023 Earnings Release |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-08-10 04:15 pm | Q2 2023 Earnings Release |
2023-08-03 12:00 pm | Annual General Meeting |
2023-05-11 04:05 pm | Q1 2023 Earnings Release |
2023-02-21 04:05 pm | FY 2022 Earnings Release |
2023-02-07 | Extraordinary Shareholders Meeting |
2022-11-10 05:20 pm | Q3 2022 Earnings Release |
2022-09-12 07:00 am | H.C. Wainwright Global Investment Conference |
2022-08-31 03:30 pm | Gilmartin Group Emerging Growth Conference |
2022-08-15 04:05 pm | Interim 2022 Earnings Release |
2022-07-11 12:00 pm | Annual General Meeting |
2022-05-16 04:05 pm | Q1 2022 Earnings Release |
2022-03-28 03:00 pm | Maxim Group Virtual Growth Conference |
2022-03-28 08:30 am | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -7,86 -8,32 5.55% | -9,67 -10,5 7.55% | -8,04 -8,75 8.11% | -12,7 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,90 -8,93 11.54% | -9,61 -10,4 7.97% | -7,79 -8,55 8.81% | 0,00 |
Net income Million USD | Released Forecast Spread | -10,5 -11,5 8.97% | -9,61 -10,4 7.97% | -7,79 -8,55 8.81% | -12,4 |
EPS USD | Released Forecast Spread | -38,9 -50,9 23.58% | -13,9 -14,4 3.33% | -2,67 -4,22 36.73% | -1,38 |
Announcement Date | 28/03/22 | 21/02/23 | 21/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -2,55 -3,01 15.3% | -2,79 -3,34 16.58% | -2,73 -3,01 9.28% | -2,45 -2,71 9.57% | -1,71 -2,50 31.59% | -2,28 -2,11 -8% | -1,73 -2,21 21.49% | -1,81 -2,02 10.21% | -2,22 -2,93 24.24% | -2,51 | -2,92 | -3,30 | -4,01 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,55 -3,59 28.79% | -2,79 -3,34 16.58% | -2,73 -3,01 9.28% | -2,42 -2,71 10.37% | -1,67 -2,50 33.27% | -2,24 -2,11 -6.22% | -1,70 -2,21 22.89% | -1,72 -2,00 13.87% | -2,13 -2,89 26.11% | ||||
Net income Million USD | Released Forecast Spread | -2,55 -3,59 28.79% | -2,79 -3,34 16.58% | -2,73 -3,01 9.28% | -2,42 -2,71 10.37% | -1,67 -2,50 33.27% | -2,24 -2,11 -6.22% | -1,70 -2,21 22.89% | -1,72 -2,00 13.87% | -2,13 -2,89 26.11% | -2,40 | -2,85 | -3,20 | -3,98 |
EPS USD | Released Forecast Spread | -13,0 -6,72 -92.86% | -5,28 -6,40 17.5% | -3,84 -5,12 25% | -3,20 -3,52 9.09% | -1,92 -3,20 40% | -2,27 -2,65 14.34% | -0,63 -0,92 31.52% | -0,54 -0,63 14.29% | -0,21 -0,78 73.08% | -0,36 | -0,42 | -0,27 | -0,33 |
Announcement Date | 28/03/22 | 16/05/22 | 15/08/22 | 10/11/22 | 21/02/23 | 11/05/23 | 10/08/23 | 09/11/23 | 21/03/24 | - | - | - | - |
Past sector events for Dermata Therapeutics, Inc.
2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:15 pm | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
2024-05-09 04:10 pm | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:09 pm | XENCOR, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DRMA Stock
- Calendar Dermata Therapeutics, Inc.